FPHAX vs. BRK-B
FPHAX (Fidelity Select Pharmaceuticals Portfolio) is Health & Biotech Equities fund managed by Fidelity, while BRK-B (Berkshire Hathaway Inc.) is a stock. Over the past 10 years, FPHAX returned 11.73%/yr vs 13.14%/yr for BRK-B. At a 0.40 correlation, their price movements are largely independent.
Performance
FPHAX vs. BRK-B - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FPHAX achieves a 10.17% return, which is significantly higher than BRK-B's -3.11% return. Over the past 10 years, FPHAX has underperformed BRK-B with an annualized return of 11.73%, while BRK-B has yielded a comparatively higher 13.14% annualized return.
FPHAX
- 1D
- -0.78%
- 1M
- 6.37%
- YTD
- 10.17%
- 6M
- 11.79%
- 1Y
- 40.05%
- 3Y*
- 17.98%
- 5Y*
- 13.47%
- 10Y*
- 11.73%
BRK-B
- 1D
- -0.23%
- 1M
- 2.32%
- YTD
- -3.11%
- 6M
- -2.06%
- 1Y
- -1.32%
- 3Y*
- 13.25%
- 5Y*
- 11.03%
- 10Y*
- 13.14%
FPHAX vs. BRK-B - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | 10.17% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 31.73% | 5.41% | 10.70% |
BRK-B Berkshire Hathaway Inc. | -3.11% | 10.89% | 27.09% | 15.46% | 3.31% | 28.95% | 2.37% | 10.93% | 3.01% | 21.62% |
Correlation
The correlation between FPHAX and BRK-B is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.39 |
Correlation (All Time) Calculated using the full available price history since Jun 19, 2001 | 0.40 |
The correlation between FPHAX and BRK-B shifts across timeframes, from 0.21 (1 year) to 0.40 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FPHAX vs. BRK-B — Risk / Return Rank
FPHAX
BRK-B
FPHAX vs. BRK-B - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FPHAX | BRK-B | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.18 | ||
| Sortino ratioReturn per unit of downside risk | +2.95 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.00 | +0.35 |
| Calmar ratioReturn relative to maximum drawdown | 4.09 | -0.14 | +4.24 |
| Martin ratioReturn relative to average drawdown | 10.66 | -0.30 | +10.96 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FPHAX | BRK-B | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.08 | -0.09 | +2.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.75 | 0.65 | +0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.66 | 0.68 | -0.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.55 | 0.48 | +0.07 |
Drawdowns
FPHAX vs. BRK-B - Drawdown Comparison
The maximum FPHAX drawdown since its inception was -38.26%, smaller than the maximum BRK-B drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for FPHAX and BRK-B.
Loading charts...
Drawdown Indicators
| FPHAX | BRK-B | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.26% | -53.86% | +15.60% |
Max Drawdown (1Y)Largest decline over 1 year | -10.33% | -9.42% | -0.91% |
Max Drawdown (3Y)Largest decline over 3 years | -28.82% | -14.95% | -13.87% |
Max Drawdown (5Y)Largest decline over 5 years | -28.82% | -26.58% | -2.24% |
Max Drawdown (10Y)Largest decline over 10 years | -28.82% | -29.57% | +0.75% |
Current DrawdownCurrent decline from peak | -0.78% | -9.78% | +9.00% |
Average DrawdownAverage peak-to-trough decline | -9.17% | -11.07% | +1.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.96% | 4.49% | -0.53% |
Volatility
FPHAX vs. BRK-B - Volatility Comparison
Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a higher volatility of 5.71% compared to Berkshire Hathaway Inc. (BRK-B) at 3.98%. This indicates that FPHAX's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FPHAX | BRK-B | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.71% | 3.98% | +1.73% |
Volatility (6M)Calculated over the trailing 6-month period | 14.25% | 10.87% | +3.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.30% | 14.38% | +5.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.07% | 17.13% | +0.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.88% | 19.44% | -1.56% |
Dividends
FPHAX vs. BRK-B - Dividend Comparison
FPHAX's dividend yield for the trailing twelve months is around 5.05%, while BRK-B has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BRK-B Berkshire Hathaway Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.05% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
Frequently Asked Questions
FPHAX and BRK-B have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FPHAX has higher volatility (5.71%) compared to BRK-B (3.98%). In terms of maximum drawdown, FPHAX dropped -38.26% vs BRK-B's -53.86%.
FPHAX currently has the higher Sharpe Ratio (2.08 vs -0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FPHAX and BRK-B
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer